Skip to Department Links Skip to Content
Endocrine Surgery Fellowship

Endocrine Surgery Fellowship

The Endocrine Surgery Fellowship provides intensive training in the diagnosis and treatment of endocrine diseases, experience in a multidisciplinary approach to treatment planning and opportunities for collaborative clinical and basic research.


The Endocrine Surgery Fellowship Program was established by
Massachusetts General Hospital and Brigham and Women's Hospital in accordance with guidelines from the American Association of Endocrine Surgeons (AAES). One fellow will be chosen at each institution, where he or she will spend approximately 11 months. For the other month, the fellows will switch institutions.

The first year of this two-year program is clinical and is mandatory for all fellows. The second year is an optional research year, based upon the specific interests of the fellow and the availability of funding. In the second year, 80% of the time will be devoted to research activities. The other 20% of the time will be spent in clinically related activities that will include participation in clinical teaching rounds and conferences and outpatient clinical activities.

The second-year fellow will continue to work on the clinical research projects selected during the first year and will be actively involved in maintaining the endocrine surgery database and coordinating specific research projects. Ample opportunity also exists for basic science research in endocrine diseases. In addition, the second-year fellow is expected to exert leadership in the teaching activities within the division. The fellow will work under the guidance and mentorship of Fellowship Program Director Dr. Sareh Parangi, along with the other Endocrine Surgery faculty.


Candidates for the fellowship must be board-eligible graduates of a general surgery residency program.


This section describes objectives and curricula for the first and second years of the Endocrine Surgery Fellowship.

First Year

Goals and Objectives

  • Demonstrate knowledge and understanding of endocrine gland anatomy and physiology, both the normal and pathological states
  • Demonstrate the ability to diagnosis clinical endocrinopathies associated with endocrine surgical diseases
  • Develop the knowledge of the inherited endocrine disorders and understand the role genetic counseling and testing
  • Have an appreciation of the current controversies and current areas of research in the literature within endocrine surgical diseases
  • Demonstrate the ability to apply this knowledge and safely perform the appropriate surgical operation for the given endocrine surgical disease


A. Develop an understanding of the normal anatomy, histology, physiology, biochemistry of each of the following endocrine glands. Be able to discuss the secretion and homeostasis of the pertinent hormonal secretion of these glands in both the normal and pathological disease states:

  • Thyroid gland
    • Thyroxine, thyroid stimulating hormone (TSH), calcitonin
    • Manifestations of hyperthyroidism and hypothyroidism
  • Parathyroid gland
    • Calcium / Phosphate / Vitamin D
    • Clinical symptoms and end organ effects associated with hyperparathyroidism (HPT)
    • Short- and long-term manifestations of hypoparathyroidism
  • Endocrine pancreas
    • Insulin / Gastrin / Glucagon / Vasoactive Intestinal Peptide (VIP) / Pancreatic Polypeptide (PP) / Somatostatin / Secretin / Cholecystokinin (CCK)
    • Clinical manifestations of hyperinsulinemia
    • Clinical manifestations of Zollinger / Elision syndrome
    • Clinical manifestations of Glucagonoma syndrome
    • Clinical manifestations of VIPoma
  • Adrenal glands
    • Aldosterone / Renin / Angiotensin
    • Adrenocorticotropic hormone (ACTH) / Cortisol
    • DHEA-S
    • Catecholamines (epinephrine, norepinephrine, dopamine)
  • Gastrointestinal tract
    • Serotonin / Histamine / Motilin / Gastric Inhibitory Peptide / Enteroglucagon / Chromogranin A
    • Manifestations of Carcinoid Syndrome
    • Gastric Physiology
  • Hypothalamus / Pituitary gland
    • Oxytocin/Vasopressin / Growth hormone / Melanocyte stimulating hormone / Prolactin

B. Endocrine Cytopathology and Histopathology

  • Thyroid
    • Classification of thyroid malignancies
    • Classification of benign thyroid disease
    • The limitations of Frozen Section results
    • Fine-needle aspiration biopsy (FNA); its application and limitations
  • Parathyroid
    • Definitions of hyperplasia vs. adenoma
    • Criteria for parathyroid carcinoma
  • Adrenal
    • Classification and diagnosis of adrenal lesions
  • Neuroendocrine Tumors (NET) of the GI tract
    • WHO classification of NET
    • Foregut / midgut / hindgut classification
    • Prognostic factors for NET
  • Hereditary Endocrine Syndromes
    • Define oncogene and tumor suppressor gene
    • Define for each endocrine hereditary syndrome the chromosomal abnormalities
    • Discuss the role of genetic screening
    • Be able to discuss and differentiate the phenotype and genotype of;
    • MEN I (multiple endocrine neoplasia)
    • MEN IIa
    • MEN IIb
    • Develop a knowledge about the endocrine pathology associated with familial non-MEN syndromes, including:
      • von Hippel Lindau (VHL)
      • Neurofibromatosis
      • Paraganglioma syndromes (SDH-B, SDH-D)
      • Cowden's Disease
      • Familial HPT
      • Jaw-Tumor Syndrome
      • Familial Medullary thyroid cancer (MTC)
      • Carney Complex
      • Carney's Triad

C. Discuss the pathophysiology, clinical presentation, work-up, and treatment (include both surgical and medical options) of the following diseases. Describe the natural history and list any prognostic factors associated with the disease.

  • Thyroid
    • A solitary thyroid nodule
    • A multinodular thyroid gland
    • Thyrotoxicosis, including toxic adenoma, Graves' disease and Hashimoto's disease
    • Well-differentiated thyroid cancer (WDTC), including I 131 ablation
    • Rare thyroid malignancies, including MTC, Lymphoma and Anaplastic
  • Parathyroid
    • Primary, secondary, and tertiary hyperparathyroidism (HPT)
    • Parathyroid carcinoma
    • Familial forms of HPT
  • Endocrine Pancreas
    • Insulinoma
    • Gastrinoma
    • Glucagonoma
    • VIPoma
    • Somatostatinoma
    • PPoma
    • Non-functioning NET of the pancreas
  • GI Neuroendocrine Tumors
    • Gastric Carcinoids Type I, II and III - including atypical Carcinoid Syndrome
    • Mid-gut (Carcinoid) tumors - including diagnosis and treatment of Carcinoid Syndrome
    • Appendiceal Carcinoids
    • Rectal Carcinoid Tumors
  • Adrenal
    • Primary hyperaldosteronism
    • Endogenous hypercortisolism (Cushing's syndrome vs. Cushing's disease)
    • Pheochromocytoma / Paraganglioma syndromes
    • The incidentally discovered adrenal mass
    • Virilizing adrenal tumors
    • Adrenal cortical carcinoma

D. Discuss the peri-operative management of the following:

  • Thyroid
    • Thyroid "storm" and thyrotoxicosis
    • Graves’ disease / Hashimoto's disease
  • Parathyroid
    • Hypercalcemic crisis
    • Hungry bone disease
    • Vitamin D deficiency
  • Adrenal
    • Pheochromocytoma / Paraganglioma syndromes - including blockade
    • Hyperaldosteronism
    • Endogenous hypercortisolism
    • Adrenal insufficiency crisis (Addison's disease)
  • NET
    • Insulinoma / Gastrinoma
    • Carcinoid syndrome and carcinoid crisis

E. Outline the differential diagnosis of:

  • Thyroid
    • Suppressed TSH level
    • Elevated serum thyroxine level
    • Lateral neck mass
    • Airway obstruction
  • Parathyroid
    • Hypercalcemia
    • Elevated PTH level
  • NET
    • Hypoglycemia
    • Hypergastrinemia
    • Secretory diarrhea
  • Adrenal
    • Elevated Cortisol levels
    • Surgical hypertension

F. Be able to describe and develop the surgical skills to perform safely many of the following surgical procedures. Recognize the potential complications and alternative treatment options of each procedure:

  • Thyroid
    • A retrosternal goiter
    • Thyroid lobectomy
    • Total / near-total thyroidectomy
    • Compartment-oriented lymph node dissections of the neck
    • Reoperative / completion thyroidectomy
  • Parathyroid
    • Finding the inferior parathyroid glands
    • Finding the superior parathyroid glands
    • Finding ectopic parathyroid glands
    • Reoperative parathyroidectomy
  • Adrenal
    • The left adrenal gland (anterior, laparoscopic and posterior)
    • The right adrenal gland (anterior, laparoscopic and posterior)
    • Retroperitoneal lymph node dissection
  • Neuroendocrine Tumors
    • The head of the pancreas
    • The body / tail of the pancreas
    • GI NET disease. including bowel resection and mesenteric nodal dissection
    • Principles of liver resection and radiofrequency ablation

G. Identify and discuss potential areas of controversy in the field of endocrine surgery, including:

  • Zollinger-Ellison syndrome (with and without MEN I)
  • Genetic screening for familial endocrine syndromes
  • Operative approach to HPT - including imaged directed, unilateral and four-gland exploration with and without iPTH
  • Management of WDTC - including I131 ablation, utilization of rhTSH, and cancer surveillance
  • Utility of laparoscopic adrenalectomy for large tumors.

H. Understand the role and apply the appropriate utilization of the following imaging and diagnostic studies in the surgical management of endocrine surgical disease:

  • Imaging modalities:
    • Ultrasound
      • Understand the role and importance of surgeon-performed ultrasound
      • Identify normal structures visualized during ultrasound of the head and neck, and be able to identify thyroid nodules, parathyroid adenomas and adenopathy
      • Be able to use US to  identify which features of a thyroid nodule on ultrasound are more worrisome for malignancy and perform a fine needle aspiration of thyroid and parathyroid.
    • CT, MRI, PET
    • Scintigraphy, including meta-iodo benzylguanine [MIBG], sestamibi, Octreotide scan, NP-59 scan
    • Selective venous sampling (parathyroid and adrenal)
    • Intraoperative tumor localization (gamma probe, Intra-Op U/S)
  • Diagnostic assays:
    • TSH, T3, T4, thyroglobulin
    • Calcitonin
    • PTH and intra-operative PTH assays
    • Chromogranin A
    • Urinary 5-HIAA
    • Insulin: Glucose ratio
    • Metanephrine (plasma and urinary)
    • Urinary free Cortisol / Midnight Salivary Cortisol
    • Dexamethasone suppression testing
    • Cortisyn stimulation testing
    • Aldosterone / Renin
  • Pathological assessment
    • FNA of the thyroid gland (limitations and selective utilization)
    • Frozen sections (limitations and appropriate utilization)
    • Immunohistochemical staining, including Ki67
    • Diagnostic criteria of malignancy in NET

I. Research and Critical Appraisal

  • Understand the design of both clinical and basic science research studies
  • Develop a basic understanding of the statistical methods applied to various study designs
  • Develop a basic knowledge of molecular biology as it applies to endocrine surgical diseases
  • Be able to critical appraise the medical literature.
  • Develop a research question in Endocrine Surgical disease and pursue an appropriate research project during the fellowship with the goal toward peer review publication

Enabling Objectives

A. Complete a detailed evaluation of patients suspected of having an endocrine disease. Collaborate in the diagnostic work up of patients and direct the appropriate investigations.

B. Participate and manage the pre- and post-operative care of patients undergoing surgery of the thyroid, parathyroid, adrenal and neuroendocrine tumors.

C. Perform and / or assist in the performance of the following surgical procedures:

  • Thyroid
    • A retrosternal goiter / multinodular goiter
    • Thyroid lobectomy
    • Total / near-total thyroidectomy
    • Compartment-oriented lymph node dissections of the neck
    • Reoperative / completion thyroidectomy
    • Direct laryngoscopy
    • Head and neck U/S
  • Parathyroid
    • Finding the inferior parathyroid glands
    • Finding the superior parathyroid glands
    • Finding ectopic parathyroid glands
    • Reoperative parathyroidectomy
    • Imaged directed / unilateral / four gland exploration
    • Subtotal / total parathyroidectomy with autotransplantation
  • Adrenal
    • The left adrenal gland (anterior, laparoscopic and posterior)
    • The right adrenal gland (anterior, laparoscopic and posterior)
    • Retroperitoneal lymph node dissection
    • En bloc retroperitoneal dissection for malignancy
  • Neuroendocrine Tumors
    • Resection / enucleation of NET in the pancreas
    • NET associated with MEN I syndrome (Thompson Procedure)
    • GI NET disease including bowel resection and mesenteric nodal dissection
    • Perform / understand the principles of liver resection and radiofrequency ablation

D. Be able to interpret and appropriately order endocrine diagnostic testing and imaging studies for each of the following endocrine glands:

  • Thyroid
  • Parathyroid
  • Adrenal
  • GI NET
  • Endocrine pancreas

E. Spend quality time working under the direct supervision of a cytopathologist and anatomical pathologist.

F. Spend quality time with the Endocrinology service, focusing on pre-operative evaluation of endocrine surgical diseases. Knowledge gained should include the peri-operative management of hormones, including insulin, octreotide, and thyroid hormone.

G. To have exposure to and/or to work with colleagues in other disciplines related to the diagnoses and treatment of endocrine surgical disease, such as:

  • Nuclear medicine
  • Medical oncology
  • Genetics
  • Interventional radiology
  • Gastroenterology

H. Be able to evaluate patients with complex endocrine disease and present a differential diagnosis and an appropriate algorithm for their care.

I. Gain experience in performing clinical and/or basic science research. Be able to collect and analyze data. Participate and/or present at journal club and surgical rounds related to endocrine surgical diseases. Develop experience in writing articles and orally presenting research studies at local and national meetings.

Second Year

Goals and Objectives

  • Understand the design of both clinical and basic science research studies.
  • Develop a basic understanding of the statistical methods applied to various study designs.
  • Develop a basic knowledge of molecular biology as it applies to endocrine surgical diseases.
  • Be able to critically appraise the medical literature.
  • Develop a research question in endocrine surgical disease, conduct a study, evaluate the results, and create a presentation or a manuscript suitable for a peer review publication.
  • The fellow will be expected to present his/her work in a variety of settings, including Mass General Department of Surgery Research Seminars, as well as at national meetings.


All fellows are required to attend and participate in the weekly conferences and meetings, including:

  • Departmental Grand Rounds (each Thursday from 8:30 – 9:30 AM).
  • Endocrine Surgery weekly meeting (each Wednesday 7:00 – 8:00 AM): The fellow will be responsible for selecting topics for resident education and coordinating the meetings.
  • Endocrine Surgery ward rounds (once every two months, Tuesday 5:00 – 6:00 PM): The Endocrine Surgery fellow will coordinate with the general surgery residents specific cases and topics for discussion. The trainee will direct the conference and formulate teaching aims for residents and medical students.
  • Endocrinology fellows’ conference – weekly meeting (Tuesday 10:15 – 11:15 AM). S/he would also present a case and topic of discussion at one of the meetings during the year.
  • Calcium Rounds weekly meeting, to be alternated with surgical grand rounds, depending on topics of discussion.
  • Center for Clinical Effectiveness (CCES) meeting once a month. The CCES sponsors the department of surgery databases (including the endocrine surgery database). At the monthly meeting, outcomes research projects that are ongoing in the Department of Surgery are presented. The trainee will attend the monthly meeting in order to gain exposure to database organization and development, as well as outcomes research. The trainee will also present at one of the monthly meetings on the status of endocrine surgery research at Mass General.
  • Weekly seminars in cancer biology and endocrinology.
  • Active participant in weekly lab meetings.

Supervision and Evaluation

The fellow will meet two days per week with the project mentor and the program director to go over the research plan, new ideas and any difficulties. These meetings will be one on one; recent research will be reviewed as well as discussing recent work from other labs, important unsolved questions in the field and strategies for approaching them. The fellow will meet with the program director on a quarterly basis to assess whether or not personal goals and objectives are being met and to review the evaluations from the previous quarter.

Clinical Experience

Richard Hodin, MD (left), and fellow perform a surgical procedure
Richard Hodin, MD (left), and fellow perform a surgical procedure.

The fellow should anticipate participation in more than 300 operations, including thyroidectomy, parathyroidectomy, neck dissections, adrenalectomy, and pancreas cases. Training will include a broad experience in complex endocrine surgery cases, including re-operative parathyroid surgery, laparoscopic adrenalectomy and extensive neck dissections. The fellow will be an integral part of the surgical team and will follow patients in the hospital post-operatively. He/she should expect to participate in the endocrine surgery clinics 2-3 times per week. This includes training in office-based ultrasound and U/S guided FNA techniques, as well as fiberoptic laryngoscopy.

The fellow will also participate in weekly conferences devoted to Endocrine Surgery and Surgical Oncology. There will be opportunity for the fellow to both attend and present patients at these conferences. We will also provide the opportunity for exposure to endocrinology, radiology, pathology/cytology and nuclear medicine.

Research Experience

The fellow will have the opportunity to participate in both basic and clinical research initiatives in endocrine surgery, including ongoing studies that use an endocrine surgery database. We expect that the fellow will have the opportunity to present their data at national meetings and submit manuscripts to peer-reviewed journals. The second year of the fellowship is optional, based upon the interests of the fellow and the availability of funding, and will be devoted to clinical and/or basic research.

Current & Past Fellows

Current Fellow

Heather Wachtel, MD
Dr. Wachtel received her undergraduate degree from Harvard University, graduating magna cum laude.  She then received her MD degree from the Yale University School of Medicine.  She completed general surgery residency at the Hospital of the University of Pennsylvania, including two years of clinical and translational research in Endocrine Surgery, with numerous national presentations and peer-reviewed publications.  Her research interests include primary hyperaldosteronism, pheochromocytoma/paraganglioma, adrenal malignancies, and thyroid and parathyroid disorders.

Past Fellows

  • Abbey Fingeret, MD (2015-2016)
    Doctorate of Medicine, Drexel University College of Medicine
  • Tammy Holm, MD, PhD (2014-2015)
    Staff Surgeon, Newton-Wellesly Hospital
  • Hyunsuk Suh, MD (2013-2014)
    Assistant Professor of Surgery, Icahn School of Medicine at Mount Sinai
    Attending, Department of Surgery at Mount Sinai Beth Israel
  • Travis J. McKenzie, MD (2012-2013) 
    Assistant Professor of Surgery
    Associate Program Director, General Surgery Residency
    Mayo Clinic
  • Jason D. Prescott, MD, PhD (2011-2012)
    Director of Thyroid and Parathyroid Surgery
    Assistant Professor of Surgery and Oncology
    Johns Hopkins School of Medicine
  • Dana Yip, MD (2011-2012)
    Clinical Assistant Professor of Surgery
    Stanford School of Medicine
  • Roy Phitayakorn, MD, MHPE (MEd), FACS (2009-2012)
    Assistant Professor of Surgery, Harvard Medical School
    Director of Surgical Education Research, Mass General
    Surgical Lead, Strategic Initiatives and Operations, Mass General Learning Laboratory
  • Carrie C. Lubitz, MD, MPH (2008-2010)
    Assistant Professor of Surgery, Harvard Medical School
    Instructor in Surgery, Mass General
  • Michal Mekel, MD (2007-2009)
    Director, Endocrine Surgery Service
    Department of General Surgery, Rambam Health Care Campus
    Clinical Lecturer, Technion-Israel Institute of Technology



View select publications from our fellows:

Tammy Holm, MD, PhD

  • Varmeh S, Borre PV, Gunda V, Brauner E, Holm T, Wang Y, Sadreyev RI, Parangi S. "Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines." Surgery. 2015 Oct. [Epub ahead of print]
  • Marti JL, Holm T, Randolph G. "Universal Use of Intraoperative Nerve Monitoring by Recently Fellowship-Trained Thyroid Surgeons is Common, Associated with Higher Surgical Volume, and Impacts Intraoperative Decision-Making." World J Surg. 2015 Sep. [Epub ahead of print]
  • View full list at PubMed

Hyunsuk Suh, MD

  • Manuscript submitted: Su-jin Kim, Jun Pyo Myong, Hyunsuk Suh, Kyu Eun Lee, Yeo-Kyu Youn. "Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer." Annals of Surgical Oncology
  • Morrison S, Suh H, Hodin R. “Surgical Management of Thyroid Cancer.” Rambam Maimonides Medical Journal. April 2014
  • Suh H, Parangi S. “The Role of Genetic Markers in the Evaluation and Management of Thyroid Nodules.” Surgical Clinic of North America. Epub 2014 Apr.
  • View full list at PubMed

Travis McKenzie, MD

  • McKenzie T, Chen Y, Hodin R, et al. "Recalcitrant Hypocalcemia after Thyroidectomy in Patients with Previous Roux-en-Y Gastric Bypass." Surgery. 2013 Dec
  • Onkendi E, McKenzie T, Richards M, et al. "Reoperative Experience with Papillary Thyroid Cancer." World J Surg. 2013 Mar
  • Chen Y, Lubitz CC, Shikora S, Hodin R, Gaz R, Moore F, McKenzie T. "Primary Hyperparathyroidism after Roux-en-Y Gastric Bypass." Obes Surg. 2014 Sep
  • View full list at PubMed

Jason Prescott, MD, PhD

  • Prescott JD, Sadow PM, Hodin RA, Le LP, Gaz RD, Randolph GW, Stephen AE, Parangi S, Daniels GH, Lubitz CC. "BRAFV600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence." Surgery. 2012 Dec
  • Prescott JD, Parangi S. "Bilaterality in Papillary Thyroid Carcinoma: Does it Influence Prognosis?" Annals of Surgical Oncology. 2011
  • Prescott JD, Stephen AE. "Secondary and Tertiary Hyperparathyroidism." Current Surgical Therapy. 11th edition, John L Cameron, Editor. In press.
  • View full list at PubMed

Dana Yip, MD

  • Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD, Moore FD Jr, Hodin RA, Stephen AE, Sadow PM, Daniels GH, Randolph GW, Parangi S, Lubitz CC. "Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.” Surgery. 2011 Dec
  • View full list at PubMed

Roy Phitayakorn, MD, MHPE (MEd), FACS

  • Phitayakorn R, Rattner DW. "Surgical Therapy for Gastric Outlet Obstruction in Peptic Ulcer Disease." UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2010. In revision.
  • Phitayakorn R. "Minimally Invasive Thyroid Surgery and Thyroid Cancer." Minimally Invasive Thyroidectomy. Editors: Dimitrios Linos and Woong Youn Chung. Springer 2012.
  • Phitayakorn R and Hodin RA. Book review for “Surgical Mentoring: Building Tomorrow’s Leaders” by John Rombeau, Amy Goldberg, and Catherine Loveland-Jones. New York, New York, Springer, 2010. ISBN: 9-7814-4197-1906. Review published in Gastroenterology
  • View full list at PubMed

Carrie Lubitz, MD, MPH

  • Lubitz CC, Hunter G, Hamberg L, Gawande A, Ruan D, Gaz R, Parangi S, Randolph GW, Moore F, Hodin RA, Stephen AE. "Accuracy of 4D-CT in Poorly-Localized Patients with Primary Hyperparathyroidism." Surgery. 2010 Dec
  • Lubitz CC, Faquin WC, Gaz R, Parangi S, Randolph GW, Hodin RA, Stephen AE. "Metastatic Melanoma to Thyroid: A Case Report and Institutional Review." World Journal of Endocrine Surgery. 2010 May-Aug
  • Lubitz CC, Faquin WC, Yang J, Mekel M, Gaz R, Parangi S, Randolph GW, Hodin RA, Stephen AE. "Clinical and Cytological Features Predictive of Malignancy in Thyroid Follicular Neoplasms." Thyroid. 2010 Jan
  • View full list at PubMed

Michael Mekel, MD

  • Nucera C, Nehs MA, Mekel M, Zhang X, Hodin RA, Lawler J, Vania NV, Parangi S. "A novel orthotopic mouse model of human anaplastic thyroid carcinoma." Thyroid. 2009 Oct
  • Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, Gerald D, Benjamin LE, Priolo C, Puxeddu E, Finn S, Jarzab B, Hodin RA, Pontecorvi A, Nose V, Lawler J, Parangi S. "B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression." Proc Natl Acad Sci USA. 2010 Jun
  • Nucera C, Nehs M, Nagarkatti S, Sadow P, Mekel M, Fischer A, Lin P, Bollag G, Lawler J, Hodin RA, Parangi S. "Targeting BRAFV600E with PLX4720 displays potent anti migratory and invasive activity in preclinical thyroid cancer models." Oncologist. 2011
  • View full list at PubMed

How to Apply

Our clinical fellowship program is sponsored by the American Association of Endocrine Surgeons (AAES).

Please contact us with any questions.

Sareh Parangi, MD
Massachusetts General Hospital
15 Parkman Street, WACC 460
Boston, MA 02114  
617-643-4806 (phone)
617-643-4802 (fax)
Assistant: Paula Bono
Based on the information, we will offer on-site interviews over the summer that will simplify application to both Brigham and Women’s Hospital and Mass General.

Back to Top